Compare peptides

Compare peptides

This is a side-by-side of what is documented, not a ranking. Different compounds are studied for different things, in different people, at different amounts. A row that looks stronger for one compound does not make it the better choice for anyone.

5-Amino-1MQBAM15
Highest evidence tier on the pageE4 Preclinical only
Animal or in vitro work. Not demonstrated in humans.
E3 Early human evidence
Small, open-label, uncontrolled, case series, or a registered trial with no published results.
Regulatory statusNot approved for human usePreclinical (mouse studies only); not approved, no human trials
Research areaMetabolic and incretinLongevity and mitochondrial, Metabolic and incretin
Regulator-approved dose on fileNo approved doseNo approved dose
Molecular formulaC10H11N2+ (free cation); C10H11ClN2 (chloride salt)Not reliably established
Molar mass159.21 g/mol, calculated for the free cation; 194.66 g/mol, calculated for the chloride saltNot reliably established
CAS number685079-15-6 (free cation); no independently confirmed CAS number exists for the chloride salt210302-17-3
Registered trials on this siteNone linked yetNone linked yet
What is not knownEverything about this compound in a human being. No interventional trial, observational study or published case report of 5-Amino-1MQ administered to a person exists, so whether it has any effect, at any dose, with any safety profile, in a human is entirely unanswered. Any human...Everything about its effects, dosing, and safety in humans. BAM15 has never been administered to a human being in a published or registered trial. Whether its favorable mouse safety profile, relative to DNP, would translate to any degree of human safety margin. No such margin...

Full pages: 5-Amino-1MQ and BAM15. See also the clinical trial tracker and how we grade evidence.

Educational reference, not medical advice. Trial data from ClinicalTrials.gov. Everything else is drawn from the compound pages on this site, each of which cites its sources.